CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- 4 Shares withheld for taxes Chief Accounting Officer gave up 8 shares (to pay taxes)
- 4 Planned sale Head of Development sold 517 shares at $133.55 ($69,045)
- 4 Planned sale Head of Global Product Strat. sold 2,223 shares at $135.00 ($300,105)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 2,370 shares (grant or award)
- 4 Grant or award Director acquired 2,370 shares (grant or award)
- 4 Grant or award Director acquired 2,370 shares (grant or award)
- 4 Grant or award Director acquired 2,370 shares (grant or award)
- 4 Grant or award Director acquired 2,370 shares (grant or award)
- 4 Grant or award Director acquired 2,370 shares (grant or award)
- 4 Grant or award Director acquired 2,370 shares (grant or award)
- 4 Grant or award Director acquired 2,370 shares (grant or award)
- 4 Grant or award Director acquired 3,160 shares (grant or award)
- 4 Planned sale Head of Development sold 3,806 shares at $126.25 ($480,508)
- 4 Shares withheld for taxes Head of Corporate Development gave up 454 shares (to pay taxes)
- 4 Open-market buy Director bought 1,235 shares at $122.72 ($151,559)
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 8,760 shares at $150.02 ($1,314,142)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Head of Development gave up 357 shares (to pay taxes)
Page 3 of 86 · 1,714 filings